Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Safety and Efficacy of Deucravacitinib in Systemic Lupus Erythematosus
jRCT2080224856Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Sep 2019
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in systemic lupus erythematosus (SLE) comparing Deucravacitinib with Placebo (2 arms). Started Sep 2019; status: completed.
02
Drugs
deucravacitinib
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on jRCT2080224856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224856.